Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • OWL vs GSK✓SelectedUSD · GSKOWL vs GSK performance historyLatest closeAs of-2.33%11/20
Stock and ETF performance explorer

OWL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-27.4%
GSK return
+40.7%
Excess return
-68.0%
Maximum drawdown
-67.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.3%-0.1%-2.2%-2.3%
7D-9.7%-5.3%-4.4%-9.2%
30D-1.9%-3.7%+1.8%-1.5%
3M-21.1%-7.3%-13.8%-20.5%
6M-5.7%-4.2%-1.5%-5.4%
YTD-35.9%+0.9%-36.8%-36.1%
1Y-30.3%+7.3%-37.6%-30.9%
3Y-24.3%+52.7%-77.1%-31.4%
All-27.4%+40.7%-68.0%-37.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling